[ Price : $8.95]
AstraZeneca submits a BLA for tezepelumab, a potential first-in-class medicine for treating severe asthma.[ Price : $8.95]
FDA publishes an International Council for Harmonization final guidance on technical and regulatory considerations for postapprova...[ Price : $8.95]
Bayer reports positive data from a second Phase 3 study that evaluated the safety and efficacy of finerenone versus placebo when a...[ Price : $8.95]
Liquidia resubmits its NDA for LIQ861 for treating pulmonary arterial hypertension.[ Price : $8.95]
FDA posts two 2019 Form FDA-483s after inspecting two Hennepin County Medical Center clinical investigators who were cited for stu...[ Price : $8.95]
FDA expands the emergency use authorization for Pfizer-BioNTechs Covid-19 vaccine to include adolescents aged 12 through 15 years....[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Registration of Producers of Drugs and ...[ Price : $8.95]
FDA announces a 6/10 Vaccines and Related Biological Products Advisory Committee meeting to discuss Covid-19 vaccines and their us...